Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.

Source:http://linkedlifedata.com/resource/pubmed/id/21128693

CNS Drugs 2011 Jan 1 25 1 37-52

Download in:

View as

General Info

PMID
21128693